"Das Tumor Zentrum Aarau ist ein Kompetenzzentrum für Onkologie, Hämatologie und Palliative Care im Mittelland. Wir bieten eine persönliche, umfassende Betreuung von Patientinnen und Patienten mit Tumorerkrankungen an - von der Diagnose, Behandlung, Supportive und Palliative Care bis zur Nachsorge. Als eigenständiges Zentrum betreuen wir die Patientinnen und Patienten in enger Absprache mit Hausärzten und niedergelassenen Spezialisten der Hirslanden Klinik Aarau sowie nahestehenden Instituten und Zentren."

During the past decade, Hirslanden Medical Center, Tumorzentrum conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hirslanden Medical Center, Tumorzentrum" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hirslanden Medical Center, Tumorzentrum" are "Advanced Breast Cancer" (1 trials), "Biosimilar" (1 trials), "Breast Neoplasms" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "Hirslanden Medical Center, Tumorzentrum" in a lesser frequency.

Most popular intervention types in "Hirslanden Medical Center, Tumorzentrum" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Alpelisib" (1 trials), "Atezolizumab" (1 trials), "Capecitabine" (1 trials) and "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hirslanden Medical Center, Tumorzentrum" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hirslanden Medical Center, Tumorzentrum". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hirslanden Medical Center, Tumorzentrum, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hirslanden Medical Center, Tumorzentrum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".